Allelic variation in KIR2DL3 generates a KIR2DL2-like receptor with increased binding to its HLA-C ligand

Journal of Immunology

Volumn 190, Issue 12, 2013, Pages 6198-6208

  Frazier, William R ^a   Steiner, Noriko ^a   Hou, Lihua ^a   Dakshanamurthy, Sivanesan ^a   Hurley, Carolyn Katovich ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; GAMMA INTERFERON; HLA C ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL2; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR 2DL3;

ALLOTYPE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; EUROPEAN AMERICAN; FLOW CYTOMETRY; GENE AMPLIFICATION; GENE FREQUENCY; GENETIC VARIABILITY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; LIGAND BINDING; MOLECULAR DYNAMICS; MOLECULAR MODEL; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SITE DIRECTED MUTAGENESIS;

AFRICAN AMERICANS; ALLELES; AMINO ACID SEQUENCE; CLUSTER ANALYSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FLOW CYTOMETRY; GENETIC VARIATION; HLA-C ANTIGENS; HUMANS; KILLER CELLS, NATURAL; LIGANDS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; POLYMERASE CHAIN REACTION; PROTEIN BINDING; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3;

EID: 84879080648     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1300464     Document Type: Article

References (59)

1. Moretta, L., and A. Moretta. 2004. Killer immunoglobulin-like receptors. Curr. Opin. Immunol. 16: 626-633. (Pubitemid 39165891)
2. Burshtyn, D. N., A. M. Scharenberg, N. Wagtmann, S. Rajagopalan, K. Berrada, T. Yi, J. P. Kinet, and E. O. Long. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4: 77-85. (Pubitemid 26056459)
3. Campbell, K. S., M. Dessing, M. Lopez-Botet, M. Cella, and M. Colonna. 1996. Tyrosine phosphorylation of a human killer inhibitory receptor recruits protein tyrosine phosphatase 1C. J. Exp. Med. 184: 93-100. (Pubitemid 26247218)
4. Lanier, L. L., B. C. Corliss, J. Wu, C. Leong, and J. H. Phillips. 1998. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391: 703-707. (Pubitemid 28113218)
5. Uhrberg, M., N. M. Valiante, B. P. Shum, H. G. Shilling, K. Lienert-Weidenbach, B. Corliss, D. Tyan, L. L. Lanier, and P. Parham. 1997. Human diversity in killer cell inhibitory receptor genes. Immunity 7: 753-763. (Pubitemid 28064889)
6. Andersson, S., C. Fauriat, J. A. Malmberg, H. G. Ljunggren, and K. J. Malmberg. 2009. KIR acquisition probabilities are independent of self-HLA class I ligands and increase with cellular KIR expression. Blood 114: 95-104.
7. Cichocki, F., J. S. Miller, and S. K. Anderson. 2011. Killer immunoglobulin-like receptor transcriptional regulation: a fascinating dance of multiple promoters. J. Innate Immun. 3: 242-248.
8. Lanier, L. L. 2005. NK cell recognition. Annu. Rev. Immunol. 23: 225-274. (Pubitemid 40563170)
9. Yu, J., G. Heller, J. Chewning, S. Kim, W. M. Yokoyama, and K. C. Hsu. 2007. Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J. Immunol. 179: 5977-5989.
10. Lanier, L. L. 2008. Up on the tightrope: natural killer cell activation and inhibition. Nat. Immunol. 9: 495-502. (Pubitemid 351560518)
11. Seliger, B., U. Ritz, and S. Ferrone. 2006. Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation. Int. J. Cancer 118: 129-138. (Pubitemid 41681589)
12. Kim, S., J. Poursine-Laurent, S. M. Truscott, L. Lybarger, Y. J. Song, L. Yang, A. R. French, J. B. Sunwoo, S. Lemieux, T. H. Hansen, and W. M. Yokoyama. 2005. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436: 709-713. (Pubitemid 41117274)
13. Kim, S., J. B. Sunwoo, L. Yang, T. Choi, Y. J. Song, A. R. French, A. Vlahiotis, J. F. Piccirillo, M. Cella, M. Colonna, et al. 2008. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105: 3053-3058. (Pubitemid 351723666)
14. Traherne, J. A., M. Martin, R. Ward, M. Ohashi, F. Pellett, D. Gladman, D. Middleton, M. Carrington, and J. Trowsdale. 2010. Mechanisms of copy number variation and hybrid gene formation in the KIR immune gene complex. Hum. Mol. Genet. 19: 737-751.
15. Pyo, C. W., L. A. Guethlein, Q. Vu, R. Wang, L. Abi-Rached, P. J. Norman, S. G. Marsh, J. S. Miller, P. Parham, and D. E. Geraghty. 2010. Different patterns of evolution in the centromeric and telomeric regions of group A and B haplotypes of the human killer cell Ig-like receptor locus. PLoS ONE 5: e15115.
16. Wilson, M. J., M. Torkar, A. Haude, S. Milne, T. Jones, D. Sheer, S. Beck, and J. Trowsdale. 2000. Plasticity in the organization and sequences of human KIR/ILT gene families. Proc. Natl. Acad. Sci. USA 97: 4778-4783. (Pubitemid 30238634)
17. Hsu, K. C., S. Chida, D. E. Geraghty, and B. Dupont. 2002. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol. Rev. 190: 40-52. (Pubitemid 36071925)
18. Moesta, A. K., P. J. Norman, M. Yawata, N. Yawata, M. Gleimer, and P. Parham. 2008. Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3. J. Immunol. 180: 3969-3979.
19. Mandelboim, O., H. T. Reyburn, M. Valés-Gómez, L. Pazmany, M. Colonna, G. Borsellino, and J. L. Strominger. 1996. Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules. J. Exp. Med. 184: 913-922.
20. Robinson, J., J. A. Halliwell, H. McWilliam, R. Lopez, and S. G. Marsh. 2013. IPD - the Immuno Polymorphism Database. Nucleic Acids Res. 41(Database issue): D1234-D1240.
21. Single, R. M., M. P. Martin, X. Gao, D. Meyer, M. Yeager, J. R. Kidd, K. K. Kidd, and M. Carrington. 2007. Global diversity and evidence for coevolution of KIR and HLA. Nat. Genet. 39: 1114-1119. (Pubitemid 47342436)
22. Gendzekhadze, K., P. J. Norman, L. Abi-Rached, T. Graef, A. K. Moesta, Z. Layrisse, and P. Parham. 2009. Co-evolution of KIR2DL3 with HLA-C in a human population retaining minimal essential diversity of KIR and HLA class I ligands. Proc. Natl. Acad. Sci. USA 106: 18692-18697.
23. Carr, W. H., M. J. Pando, and P. Parham. 2005. KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand. J. Immunol. 175: 5222-5229. (Pubitemid 41456407)
24. Lavender, K. J., H. H. Chau, and K. P. Kane. 2007. Distinctive interactions at multiple site 2 subsites by allele-specific rat and mouse ly49 determine functional binding and class I MHC specificity. J. Immunol. 179: 6856-6866.
25. Jonsson, A. H., L. Yang, S. Kim, S. M. Taffner, and W. M. Yokoyama. 2010. Effects of MHC class I alleles on licensing of Ly49A+ NK cells. J. Immunol. 184: 3424-3432.
26. VandenBussche, C. J., S. Dakshanamurthy, P. E. Posch, and C. K. Hurley. 2006. A single polymorphism disrupts the killer Ig-like receptor 2DL2/2DL3 D1 domain. J. Immunol. 177: 5347-5357. (Pubitemid 44527607)
27. Winter, C. C., J. E. Gumperz, P. Parham, E. O. Long, and N. Wagtmann. 1998. Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161: 571-577. (Pubitemid 28323516)
28. Khakoo, S. I., C. L. Thio, M. P. Martin, C. R. Brooks, X. Gao, J. Astemborski, J. Cheng, J. J. Goedert, D. Vlahov, M. Hilgartner, et al. 2004. HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305: 872-874. (Pubitemid 39038423)
29. Cooley, S., D. J. Weisdorf, L. A. Guethlein, J. P. Klein, T. Wang, C. T. Le, S. G. Marsh, D. Geraghty, S. Spellman, M. D. Haagenson, et al. 2010. Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia. Blood 116: 2411-2419.
30. Chazara, O., S. Xiong, and A. Moffett. 2011. Maternal KIR and fetal HLA-C: a fine balance. J. Leukoc. Biol. 90: 703-716.
31. Hou, L., M. Chen, N. Steiner, K. Kariyawasam, J. Ng, and C. K. Hurley. 2012. Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing. Methods Mol. Biol. 882: 431-468.
32. Hou, L., M. Chen, J. Ng, and C. K. Hurley. 2012. Conserved KIR allele-level haplotypes are altered by microvariation in individuals with European ancestry. Genes Immun. 13: 47-58.
33. Guo, S. W., and E. A. Thompson. 1992. Performing the exact test of Hardy-Weinberg proportion for multiple alleles. Biometrics 48: 361-372.
34. VandenBussche, C. J., T. J. Mulrooney, W. R. Frazier, S. Dakshanamurthy, and C. K. Hurley. 2009. Dramatically reduced surface expression of NK cell receptor KIR2DS3 is attributed to multiple residues throughout the molecule. Genes Immun. 10: 162-173.
35. Maenaka, K., T. Juji, D. I. Stuart, and E. Y. Jones. 1999. Crystal structure of the human p58 killer cell inhibitory receptor (KIR2DL3) specific for HLA-Cw3-related MHC class I. Structure 7: 391-398. (Pubitemid 29190473)
36. Sidney, J., M. F. del Guercio, S. Southwood, V. H. Engelhard, E. Appella, H. G. Rammensee, K. Falk, O. Rötzschke, M. Takiguchi, R. T. Kubo, et al. 1995. Several HLA alleles share overlapping peptide specificities. J. Immunol. 154: 247-259.
37. Graef, T., A. K. Moesta, P. J. Norman, L. Abi-Rached, L. Vago, A. M. Older Aguilar, M. Gleimer, J. A. Hammond, L. A. Guethlein, D. A. Bushnell, et al. 2009. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206: 2557-2572.
38. Neisig, A., C. J. Melief, and J. Neefjes. 1998. Reduced cell surface expression of HLA-C molecules correlates with restricted peptide binding and stable TAP interaction. J. Immunol. 160: 171-179. (Pubitemid 28116727)
39. GraphPad Prism version 5.0f for Macintosh. GraphPad Software, La Jolla, CA.
40. R Development Core Team. A Language and Environment for Statistical Computing. 2.15.2 ed. R Foundation for Statistical Computing, Vienna, Austria.
41. McQuitty, L. L. 1966. Similarity Analysis by Reciprocal Pairs for Discrete and Continuous Data. Educ. Psychol. Meas. 26: 825-831.
42. Fauriat, C., E. O. Long, H. G. Ljunggren, and Y. T. Bryceson. 2010. Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115: 2167-2176.
43. Case, D. A., T. A. Darden, T. E. Cheatham III, C. L. Simmerling, J. Wang, R. E. Duke, R. Luo, K. M. Merz, D. A. Pearlman, M. Crowley, et al. 2008. AMBER 10. University of California, San Francisco, San Francisco, CA.
44. Sivanesan, D., R. V. Rajnarayanan, J. Doherty, and N. Pattabiraman. 2005. Insilico screening using flexible ligand binding pockets: a molecular dynamics-based approach. J. Comput. Aided Mol. Des. 19: 213-228. (Pubitemid 41386819)
45. Berendsen, H. J. C., J. P. M. Postma, W. F. van Gunsteren, A. DiNola, and J. R. Haak. 1984. Molecular dynamics with coupling to an external bath. J. Chem. Phys. 81: 3684.
46. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald: An N·log(N) method for Ewald sums in large systems. J. Chem. Phys. 98: 10089.
47. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
48. Tamura, K., D. Peterson, N. Peterson, G. Stecher, M. Nei, and S. Kumar. 2011. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28: 2731-2739.
49. Middleton, D., A. Meenagh, and P. A. Gourraud. 2007. KIR haplotype content at the allele level in 77 Northern Irish families. Immunogenetics 59: 145-158. (Pubitemid 46130793)
50. Maenaka, K., T. Juji, T. Nakayama, J. R. Wyer, G. F. Gao, T. Maenaka, N. R. Zaccai, A. Kikuchi, T. Yabe, K. Tokunaga, et al. 1999. Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274: 28329-28334.
51. Falco, M., E. Romeo, S. Marcenaro, S. Martini, M. Vitale, C. Bottino, M. C. Mingari, L. Moretta, A. Moretta, and D. Pende. 2010. Combined genotypic and phenotypic killer cell Ig-like receptor analyses reveal KIR2DL3 alleles displaying unexpected monoclonal antibody reactivity: identification of the amino acid residues critical for staining. J. Immunol. 185: 433-441.
52. Fan, Q. R., L. Mosyak, C. C.Winter, N.Wagtmann, E. O. Long, and D. C. Wiley. 1997. Structure of the inhibitory receptor for human natural killer cells resembles haematopoietic receptors. Nature 389: 96-100. (Pubitemid 27387699)
53. Snyder, G. A., A. G. Brooks, and P. D. Sun. 1999. Crystal structure of the HLACw3 allotype-specific killer cell inhibitory receptor KIR2DL2. Proc. Natl. Acad. Sci. USA 96: 3864-3869. (Pubitemid 29169002)
54. Moesta, A. K., T. Graef, L. Abi-Rached, A. M. Older Aguilar, L. A. Guethlein, and P. Parham. 2010. Humans differ from other hominids in lacking an activating NK cell receptor that recognizes the C1 epitope of MHC class I. J. Immunol. 185: 4233-4237.
55. Rajagopalan, S., and E. O. Long. 1997. The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185: 1523-1528. (Pubitemid 27187611)
56. Falk, K., O. Rötzschke, B. Grahovac, D. Schendel, S. Stevanović, V. Gnau, G. Jung, J. L. Strominger, and H. G. Rammensee. 1993. Allele-specific peptide ligand motifs of HLA-C molecules. Proc. Natl. Acad. Sci. USA 90: 12005-12009. (Pubitemid 24008769)
57. Carrington, M., and M. P. Martin. 2006. The impact of variation at the KIR gene cluster on human disease. Curr. Top. Microbiol. Immunol. 298: 225-257.
58. Trowsdale, J., and A. Moffett. 2008. NK receptor interactions with MHC class I molecules in pregnancy. Semin. Immunol. 20: 317-320.
59. Murphy, W. J., P. Parham, and J. S. Miller. 2012. NK cells - from bench to clinic. Biol. Blood Marrow Transplant. 18(Suppl): S2-S7.